Dr. Keith David Goldstein, MD

Dr. Goldstein practices at Willamette Valley Cancer Institute and Research Center in Eugene, Oregon.

Dr. Goldstein's NPI, 1861462566, was assigned on January 25, 2006. Dr. Goldstein holds Oregon license MD181720.

Dr. Goldstein's primary practice is Willamette Valley Cancer Institute and Research Center, at 520 Country Club Rd, Eugene, OR 97401 in Lane County. The practice phone is (541) 683-5001.

Dr. Goldstein's primary practice is Willamette Valley Cancer Institute and Research Center in Eugene, Oregon. Dr. Goldstein is also affiliated with PeaceHealth Sacred Heart Medical Center RiverBend. The medical group on file is Willamette Valley Cancer Institute & Research Center. Dmand AI also links Dr. Goldstein to 4 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goldstein practices, 6 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Goldstein's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Goldstein is licensed in Oregon.

CMS data shows 37,400 Medicare services from Dr. Goldstein across 38 procedure codes in 2024, for 362 Medicare patients. Medicare paid $773,144 for them.

CMS counts 362 Medicare patients who saw Dr. Goldstein in 2024. The largest group is 65 to 74, with 174 patients. 70% of them have high blood pressure, and 62% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Goldstein's median patient age at 68, with 55% women.

In 2024, Dr. Goldstein wrote 977 Medicare Part D claims for 172 patients. 87% of them were for generic drugs. CMS names the drug for 771 of them, across 28 drugs with 11 or more claims each, at $1,279,801 in total drug cost. In 2023, CMS named 536 claims across 21 drugs.

Dr. Goldstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Goldstein as offering telehealth.

CMS Open Payments shows 405 general payments to Dr. Goldstein from 45 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 81% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,519.